# Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Positive Breast Cancer

> **NCT00093795** · PHASE3 · COMPLETED · sponsor: **NSABP Foundation Inc** · enrollment: 4894 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Cyclophosphamide
- **DRUG:** Docetaxel
- **DRUG:** Gemcitabine
- **DRUG:** Paclitaxel
- **DRUG:** Doxorubicin

## Key facts

- **NCT ID:** NCT00093795
- **Lead sponsor:** NSABP Foundation Inc
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** 2012-03
- **Final completion:** 2016-06
- **Target enrollment:** 4894 (ACTUAL)
- **Last updated:** 2018-01-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00093795

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00093795, "Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Positive Breast Cancer". Retrieved via MORVS 2026-10-18 from https://api.morvs.ai/clinical/NCT00093795. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*